OMX30 1 585 -0,3%  OMXH25 3 761 0,1%  OMXC20 920 -0,3%  Dow 20 743 0,6%  Nas 5 351 0,5%  EUR 9,4570 0,0%  USD 9,0056 0,3%  Olja 56,3 -0,7%  Guld 1 238 0,2% 

Regeneron Pharmaceuticals Aktie

371,46USD 0,31USD 0,08%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Regeneron Pharmaceuticals

2016 2017e 2018e 2019e 2020e
Utdelning - - - - -
Direktavkastning (i %) - - - - -
PE-tal 32,83 29,15 24,32 20,92 17,61
Resultat/aktie 11,32 13,53 16,22 18,85 22,40

Nyheter om Regeneron Pharmaceuticals Inc.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Regeneron Pharmaceuticals Inc.

ytterligare analyser

Regeneron Pharmaceuticals Peer Group

pagehit

Lägg till instrument

Vad tycker du?

Profil Regeneron Pharmaceuticals Inc.

till bolagsprofilen
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company involves in marketing medicines for eye diseases, colorectal cancer and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma and atopic dermatitis. Its products include EYLEA (aflibercept) injection, which is used for the treatment of neovascular age related macular degeneration; ARCALYST (rilonacept), which is used for the treatment of Cryopyrin-Associated Periodic Syndrome, including Familial Cold Auto-inflammatory Syndrome and Muckle-Wells Syndrome; and PRALUENT (alirocumab) Injection for treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease, who require additional lowering of LDL- C. Regeneron Pharmaceuticals was founded by Alferd G. Gilman, Leonard S. Schleifer and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Aktiekurs Regeneron Pharmaceuticals Inc. i USDPUSH CHART

Kurs 371,46 USD 0,31 0,08 %
Kurstid 21:59:53
Datum 21.02.2017
Öppning 0,00
Gårdagen 371,46
Dagshögsta 0,00
Dagslägsta 0,00
52 v. högsta 452,93
52 v. lägsta 325,56
52 v. perf.
Volym (Antal) 0
Börsvärde (SEK) 346,15 Mrd
Börsen
Kurs för 371,46 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 3 345,22 SEK.

Till aktien Regeneron Pharmaceuticals

Ticker
ISIN US75886F1075
Index NASDAQ Comp., S&P 500, NASDAQ 100, BX Swiss - USA

Regeneron Pharmaceuticals Nyckeltal

Börsvärde i SEK 346,15 Mrd
Free float % 74,71
Antal aktier mio. 104,17
Cashflow/aktie i lokal valuta 11,32
Bokvärde/aktie i lokal valuta 46,69
60 dagar vola 31,08
PBV 7,96

Regeneron Pharmaceuticals Historiska kurser

2017-02-21 371,46 25 796
2017-02-17 371,15 30 119
2017-02-16 373,02 70 712
2017-02-15 384,02 36 145
2017-02-14 376,48 40 980

Aktier i samma industri med bättre 1 års perf.

SIGA Technologies Inc. 617,7 %
Exelixis Inc. 505,8 %
Ariad Pharmaceuticals Inc. 382,2 %
Array BioPharma Inc. 323,7 %
EXACT Sciences Corp. 276,0 %